IFNA1 and Cirrhosis: This study describes, to the best of our knowledge, the first comprehensive comparison of the phenotype and function of NK subpopulations throughout a longitudinal analysis between HCV-infected patients with or without cirrhosis undergoing IFN-free therapies.